PHIO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Phio Pharmaceuticals Corp (PHIO).


$1.86M Market Cap.

As of 04/01/2024 5:00 PM ET (MRY) • Disclaimer

PHIO Market Cap. (MRY)


PHIO Shares Outstanding (MRY)


PHIO Assets (MRY)


Total Assets

$9.36M

Total Liabilities

$1.63M

Total Investments

$0

PHIO Income (MRY)


Revenue

$0

Net Income

-$10.83M

Operating Expense

$10.82M

PHIO Cash Flow (MRY)


CF Operations

-$10.75M

CF Investing

-$5.00K

CF Financing

$7.41M

PHIO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

PHIO Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$9,364,000 (-26.92%)

$12,814,000 (-49.09%)

$25,170,000 (59.92%)

$15,739,000 (95.78%)

Assets Current

$9,322,000 (-25.10%)

$12,446,000 (-49.67%)

$24,727,000 (63.06%)

$15,164,000 (107.73%)

Assets Non-Current

$42,000 (-88.59%)

$368,000 (-16.93%)

$443,000 (-22.96%)

$575,000 (-22.19%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$7,730,000 (-28.68%)

$10,838,000 (-50.58%)

$21,932,000 (68.49%)

$13,017,000 (126.46%)

Property Plant & Equipment Net

$39,000 (-88.66%)

$344,000 (-17.31%)

$416,000 (-25.31%)

$557,000 (-22.75%)

Cash & Equivalents

$8,490,000 (-28.24%)

$11,831,000 (-50.92%)

$24,107,000 (68.65%)

$14,294,000 (104.67%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$657,000 (-15.66%)

$779,000 (175.27%)

$283,000 (-61.13%)

$728,000 (-10.01%)

Accumulated Retained Earnings (Deficit)

-$139,206,000 (-8.43%)

-$128,380,000 (-9.82%)

-$116,900,000 (-12.82%)

-$103,613,000 (-9.27%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$35,000 (-79.41%)

$170,000 (-42.37%)

$295,000 (-54.05%)

$642,000 (23.94%)

Debt Current

$35,000 (-74.07%)

$135,000 (8.00%)

$125,000 (7.76%)

$116,000 (8.41%)

Debt Non-Current

$0 (0%)

$35,000 (-79.41%)

$170,000 (-67.68%)

$526,000 (27.98%)

Total Liabilities

$1,634,000 (-17.22%)

$1,974,000 (-39.04%)

$3,238,000 (18.96%)

$2,722,000 (18.81%)

Liabilities Current

$1,634,000 (-15.73%)

$1,939,000 (-36.80%)

$3,068,000 (39.71%)

$2,196,000 (16.81%)

Liabilities Non-Current

$0 (0%)

$35,000 (-79.41%)

$170,000 (-67.68%)

$526,000 (27.98%)

PHIO Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$4,366,000 (-1.89%)

$4,450,000 (-3.78%)

$4,625,000 (-8.90%)

$5,077,000 (7.84%)

Research & Development Expense

$6,332,000 (-9.70%)

$7,012,000 (-21.09%)

$8,886,000 (139.13%)

$3,716,000 (-13.58%)

Operating Expenses

$10,824,000 (-5.57%)

$11,462,000 (-15.17%)

$13,511,000 (53.66%)

$8,793,000 (-2.39%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$1,000 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.09%)

-$8,794,000 (1.28%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.09%)

-$8,794,000 (1.28%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.09%)

-$8,794,000 (1.28%)

Weighted Average Shares

$2,083,569 (83.32%)

$1,136,566 (6.30%)

$1,069,234 (179.70%)

$382,279 (895.49%)

Weighted Average Shares Diluted

$2,083,569 (83.32%)

$1,136,566 (6.30%)

$1,069,234 (179.70%)

$382,279 (895.49%)

Earning Before Interest & Taxes (EBIT)

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.11%)

-$8,793,000 (1.29%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$10,824,000 (5.57%)

-$11,462,000 (15.17%)

-$13,511,000 (-53.66%)

-$8,793,000 (2.16%)

PHIO Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-$5,000 (95.87%)

-$121,000 (-137.25%)

-$51,000 (-168.42%)

-$19,000 (73.61%)

Net Cash Flow from Financing

$7,413,000 (28611.54%)

-$26,000 (-100.12%)

$21,722,000 (34.66%)

$16,131,000 (1989.51%)

Net Cash Flow from Operations

-$10,749,000 (11.38%)

-$12,129,000 (-2.29%)

-$11,858,000 (-34.72%)

-$8,802,000 (-1.82%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,341,000 (72.78%)

-$12,276,000 (-225.10%)

$9,813,000 (34.24%)

$7,310,000 (192.01%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$5,000 (95.87%)

-$121,000 (-137.25%)

-$51,000 (-168.42%)

-$19,000 (73.61%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$204,000 (3500.00%)

Issuance (Purchase) of Equity Shares

$7,441,000 (0%)

$0 (0%)

$21,723,000 (36.37%)

$15,929,000 (1939.56%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$303,000 (-26.81%)

$414,000 (-13.75%)

$480,000 (252.94%)

$136,000 (-54.67%)

Depreciation Amortization & Accretion

$184,000 (-4.66%)

$193,000 (0.52%)

$192,000 (4.92%)

$183,000 (3.98%)

PHIO Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-134.70% (-78.41%)

-75.50% (-52.53%)

-49.50% (18.18%)

-60.50% (41.03%)

Return on Average Assets (ROAA)

-105.90% (-63.43%)

-64.80% (-44.64%)

-44.80% (12.84%)

-51.40% (36.70%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

886.70% (-43.90%)

1580.70% (-2.86%)

1627.30% (-66.55%)

4864.70% (-11.26%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.15 (66.97%)

-0.44 (54.20%)

-0.96 (31.12%)

-1.4 (-187.68%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.24 (-48.83%)

0.47 (-23.99%)

0.62 (-48.37%)

1.2 (52.04%)

Debt to Equity Ratio (D/E)

0.21 (15.93%)

0.18 (22.97%)

0.15 (-29.19%)

0.21 (-47.62%)

Earnings Per Share (EPS)

-5.2 (48.51%)

-10.1 (18.74%)

-12.43 (46.05%)

-23.04 (90.07%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-5.16 (52.12%)

-10.78 (3.23%)

-11.14 (51.73%)

-23.07 (89.83%)

Book Value Per Share (BVPS)

3.71 (-61.09%)

9.54 (-53.51%)

20.51 (-39.76%)

34.05 (-77.25%)

Tangible Assets Book Value Per Share (TABVPS)

4.49 (-60.14%)

11.27 (-52.11%)

23.54 (-42.83%)

41.17 (-80.33%)

Enterprise Value Over EBIT (EV/EBIT)

1 (0.00%)

1 (0.00%)

1 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.61 (-25.03%)

0.82 (-15.74%)

0.97 (1100.00%)

0.08 (-80.90%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

5.71 (-11.12%)

6.42 (-20.36%)

8.06 (16.73%)

6.91 (77.83%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$10,754,000 (12.21%)

-$12,250,000 (-2.86%)

-$11,909,000 (-35.01%)

-$8,821,000 (-1.19%)

Enterprise Value (EV)

-$6,529,980 (29.39%)

-$9,247,514 (27.36%)

-$12,730,308 (-1720.68%)

-$699,208 (81.11%)

Earnings Before Tax (EBT)

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.09%)

-$8,794,000 (1.28%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$10,642,000 (5.71%)

-$11,287,000 (13.81%)

-$13,095,000 (-52.09%)

-$8,610,000 (1.40%)

Invested Capital

-$725,000 (7.76%)

-$786,000 (54.04%)

-$1,710,000 (-1468.81%)

-$109,000 (64.50%)

Working Capital

$7,688,000 (-26.83%)

$10,507,000 (-51.49%)

$21,659,000 (67.02%)

$12,968,000 (139.26%)

Tangible Asset Value

$9,364,000 (-26.92%)

$12,814,000 (-49.09%)

$25,170,000 (59.92%)

$15,739,000 (95.78%)

Market Capitalization

$1,857,020 (-63.48%)

$5,084,486 (-62.43%)

$13,534,692 (-12.96%)

$15,549,792 (244.39%)

Average Equity

$8,039,500 (-47.13%)

$15,204,750 (-43.38%)

$26,855,750 (84.61%)

$14,547,000 (67.58%)

Average Assets

$10,226,500 (-42.31%)

$17,727,750 (-40.22%)

$29,656,500 (73.19%)

$17,123,500 (56.01%)

Invested Capital Average

-$1,221,000 (-68.12%)

-$726,250 (11.05%)

-$816,500 (-351.73%)

-$180,750 (-11.23%)

Shares

2,443,447 (114.53%)

1,138,997 (0.98%)

1,127,891 (134.14%)

481,716 (1104.08%)